Ruane Professor for the Implementation of Science for Child and Adolescent Mental Health, Columbia University Medical Center
WebsiteFunded Projects
SFARI Funded Publications
Intact amphetamine-induced behavioral sensitization in mice with increased or decreased neuronal glutamate transporter SLC1A1/EAAT3.
Chohan M.O., Yueh H., Fein H., Kopelman J.M., Ahmari S.E., Veenstra-VanderWeele J.
Large multicenter randomized trials in autism: Key insights gained from the balovaptan clinical development program.
Jacob S., Anagnostou E., Hollander E., Jou R. J., McNamara N., Sikich L., Tobe R., Murphy D., McCracken J., Ashford E., Chatham C., Clinch S., Smith J., Sanders K., Murtagh L., Noeldeke J., Veenstra-VanderWeele J.
Efficacy and safety of balovaptan for socialisation and communication difficulties in autistic adults in North America and Europe: A phase 3, randomised, placebo-controlled trial.
Jacob S., Veenstra-VanderWeele J., Murphy D., McCracken J., Smith J., Sanders K., Meyenberg C., Wiese T., Deol-Bhullar G., Wandel C., Ashford E., Anagnostou E.